Cirugía conservadora para las úlceras gástricas.

Same author

[Poorly differentiated large cell endocrine carcinoma of the extrahepatic bile ducts].

Gastroenterologie clinique et biologique·2009

Same author

Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients.

Surgery·2001

Same author

[Role of somatostatins in the preventin of pancreatic fistulae and the treatment of digestive fistulae].

Annales de chirurgie·2001

Same author

[Laparoscopic treatment of perforated duodenal ulcers. Results of a retrospective multicentric study. French Society of Laparoscopic Surgery].

Annales de chirurgie·2000

Same author

[Results of laparoscopic treatment of perforated ulcers].

Chirurgie; memoires de l'Academie de chirurgie·1999

Same author

[Evaluation and interest in new molecular markers in colon cancer].

Annales pharmaceutiques francaises·1998

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Videos de Experimentos Relacionados

Cirugía conservadora para las úlceras gástricas.

Videos de Conceptos Relacionados

[Poorly differentiated large cell endocrine carcinoma of the extrahepatic bile ducts].

Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients.

[Role of somatostatins in the preventin of pancreatic fistulae and the treatment of digestive fistulae].

[Laparoscopic treatment of perforated duodenal ulcers. Results of a retrospective multicentric study. French Society of Laparoscopic Surgery].

[Results of laparoscopic treatment of perforated ulcers].

[Evaluation and interest in new molecular markers in colon cancer].

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Cirugía conservadora para las úlceras gástricas.

Videos de Conceptos Relacionados

Artículos Relacionados

[Poorly differentiated large cell endocrine carcinoma of the extrahepatic bile ducts].

Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients.

[Role of somatostatins in the preventin of pancreatic fistulae and the treatment of digestive fistulae].

[Laparoscopic treatment of perforated duodenal ulcers. Results of a retrospective multicentric study. French Society of Laparoscopic Surgery].

[Results of laparoscopic treatment of perforated ulcers].

[Evaluation and interest in new molecular markers in colon cancer].

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.